 | ||||
 | | What we've been up to lately - HIV/AIDS SitesMCART played a primary role in conceptualizing and creating the systems used by many HIV/AIDS medial donation programs. We designed each Online Donation Program to have 3 targets and 3 sides: 1) A side where the public can learn about a pharma offer 2) A side where applicants can apply for the offer 3) A side where the administrator of the offer can manage the information The net result: A rich, growing body of data = Targeted Delivery & Results We found six matches.  PMTCT DonationsJanuary 2004 The PMTCT Donations Program is Abbott and Boehringer Ingelheim's joint response to Mother to Child Transmission (MTCT), the primary way that children are infected with HIV. More  Donation Program - Gilead Access Program®HIV/AIDS Donation Management with Gilead January 2003 The Gilead Access Program is designed to expand sustainable access to the once-daily anti-HIV medications Truvada® (emtricitabine and tenofovir disoproxil fumarate) and Viread® (tenofovir disoproxil fumarate) in 97 developing countries. More  Donation Program - Determine® Donation ProgramHIV/AIDS Donation Management with Abbott Laboratories January 2002 Offering Norvir® and Kaletra®, The Determine® Donation Program was Abbott's initial response to Mother to Child Transmission (MTCT), the primary way that children are infected with HIV. More  Donation Program - Diflucan Donation Programme®HIV/AIDS Donation Management with Pfizer Laboratories January 2002 The Diflucan Partnership Program includes both donations of its anti-fungal medicine, Diflucan® (fluconazole), and the training of health professionals in the diagnosis and treatment of opportunistic infections. More  Donation Program - Viramune Donation Programme®Applications for HIV/AIDS Treatment for Africa with Boehringer Ingelheim January 2001 The Viramune Donation Programme is a Boehringer Ingelheim initiative to prevent babies from being born HIV-positive. More  Donation Program - Access to HIV Care®AIDS Treatment Access with Abbott January 2001 Through the Access to HIV Care® Program, Abbott makes available Kaletra® and Norvir® at a loss to Abbott, and the HIV rapid test Determine® at no profit. More | | |
